JS Link제이에스링크
127120 · KOSDAQ · ₩127120 · 제이에스링크
Valuation model · Discounted cash flow (DCF)
We use a 5-year discounted cash flow: the value of the cash the business is expected to produce, in today's money.
Fair value per share
With these assumptions the model gives no positive value.
- Enterprise value
- −₩182B
- Equity value
- −₩160B
- WACC
- 7.3%
Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal. This is not financial advice.
Why the model and the price differ
The model gives no positive value at these assumptions. What we can see:
- No operating margin up to 90% gets the model to today's price at these growth assumptions.
- Margins ranged from −64.6% to −19.8% over the last 5 years, so this is a cyclical business. The model uses the average; the price may be set by where the cycle is now. Try the margin fade option.
- In the projection, spending on equipment, software and working capital takes most or all of the after-tax operating profit, so free cash flow is thin. Companies that invest heavily often look like this until spending slows.
Treat the model as a starting point: change the assumptions to the story you believe, and compare with the multiples check below.
Bear / Base / Bull
- Bear
- —
- Base
- —
- Bull
- —
Bear: revenue growth 3 points lower every year, EBIT margin 2 points lower, WACC 1 point higher. Bull: the opposite.
Assumptions
Sign in to change the assumptions and see the results update. Sign in
Cycle options
Margin path
Every year uses the cycle-average margin (−20.0%).
Revenue growth
- 4.4%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (4.4% a year, annual reports), fading to 3% by year 5.
- 4%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (4.4% a year, annual reports), fading to 3% by year 5.
- 3.7%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (4.4% a year, annual reports), fading to 3% by year 5.
- 3.3%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (4.4% a year, annual reports), fading to 3% by year 5.
- 3%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (4.4% a year, annual reports), fading to 3% by year 5.
Business
- -20%
Operating profit as a share of revenue.
Default: through-the-cycle average of the last 12 months and the last 5 annual reports' operating margins.
- 27.5%
Share of operating profit paid as corporate tax.
Default: Korea's top corporate tax rate (25%) plus 10% local income tax.
- 6.9%
The non-cash cost of wearing out equipment, added back to cash flow (% of revenue).
Default: average of the last 3 annual reports (cash flow statements; equipment and intangibles).
- 115.5%
Money spent on factories, equipment, software and other long-term assets (% of revenue).
Default: average of the last 3 annual reports (cash flow statements; equipment and intangibles).
- -10%
Stock and unpaid customer bills, less unpaid supplier bills, as a % of revenue. Each year's extra revenue ties up this much more cash.
Default: working capital (current assets less cash and deposits, minus current liabilities other than borrowings) as a share of revenue, averaged over the last 3 years.
Discount rate
- 2%
How fast cash flows keep growing every year after year 5.
Default: about Korea's long-run inflation plus real growth.
- 4.01%
Yield on Korea's 10-year government bond: the return with almost no risk.
Default: Korea Treasury Bond 10-year yield on 2026-10-30.
- 0.6
How much the share moves when the market moves: 1 means just like the market.
Default: 105 weeks of weekly returns against KOSPI (official index); raw beta 0.27, adjusted toward 1 and kept between 0.6 and 2.0.
- 5.5%
The extra return investors want for owning shares instead of bonds.
Default: a typical premium for Korean shares.
- 5.51%
The interest rate the company would pay to borrow.
Default: the 10-year yield plus a 1.5% credit spread.
Starting point
- Revenue (TTM to H1 2026)
- ₩23B
- Net debt (borrowings and leases − cash and deposits)
- −₩21B
- + Stakes and investments
- ₩1.4B
- Associates, long-term financial assets and deposits (book value)
- Shares
- 37,421,032
- Share price
- ₩19,200
- Market cap
- ₩718B
TTM = trailing 12 months: the last four reported quarters added together. "TTM to H1 2026" is the 12 months up to the latest quarterly or half-year report (H1 = to the end of June). Year 1 grows from there.
Past years and projection
Grey columns are reported results from the annual reports (after-tax EBIT at the model's tax rate), so you can check the growth and margin assumptions against the past. Years 1–5 are the model.
| FY2023 | FY2024 | FY2025 | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩22B | ₩16B | ₩19B | ₩24B | ₩25B | ₩26B | ₩26B | ₩27B |
| Growth | 29.3% | −27.5% | 21.4% | 4.4% | 4.0% | 3.7% | 3.3% | 3.0% |
| EBIT | −₩4.3B | −₩9.1B | −₩12B | −₩4.8B | −₩4.9B | −₩5.1B | −₩5.3B | −₩5.5B |
| EBIT margin | −19.8% | −57.3% | −64.6% | −20.0% | −20.0% | −20.0% | −20.0% | −20.0% |
| After-tax EBIT | −₩3.1B | −₩6.6B | −₩9.1B | −₩3.4B | −₩3.6B | −₩3.7B | −₩3.8B | −₩4B |
| + Depreciation | ₩1.5B | — | — | ₩1.6B | ₩1.7B | ₩1.8B | ₩1.8B | ₩1.9B |
| − Capital spending | ₩2.9B | ₩17B | ₩44B | ₩27B | ₩29B | ₩30B | ₩31B | ₩32B |
| − Working capital | −₩5.2B | −₩16B | −₩16B | −₩100M | −₩95M | −₩92M | −₩85M | −₩79M |
| Free cash flow | ₩709M | — | — | −₩29B | −₩30B | −₩31B | −₩33B | −₩34B |
| Discount factor | — | — | — | 0.932 | 0.868 | 0.809 | 0.754 | 0.703 |
| Present value | — | — | — | −₩27B | −₩26B | −₩25B | −₩25B | −₩24B |
Terminal value −₩79B, worth −₩55B today: 30% of enterprise value. It assumes spending settles at 110% of depreciation once growth slows to the terminal rate.
Cross-check: what the market has paid before
For cyclical businesses, analysts check a DCF against the multiples the stock has traded at through past cycles. Price / book is the usual anchor for them: P/E looks highest at the bottom of a cycle, when earnings are smallest, and lowest at the top. The price each band would give today:
| Low | Typical | High | |
|---|---|---|---|
| Price / book (book value ₩2,766 a share)Now 6.94× | ₩10,2383.70× | ₩14,5015.24× | ₩48,00517.4× |
Low, typical and high are the 10th percentile, middle and 90th percentile of month-end multiples since 2021, each against the latest report out by then, per share at today's share count; loss years and P/E above 100 are left out. Run-rate earnings are one quarter × 4, not a forecast. Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal.
Sensitivity
Fair value per share as two inputs change; the middle is the current case.
| WACC ↓ · Terminal growth → | 1.0% | 1.5% | 2.0% | 2.5% | 3.0% |
|---|---|---|---|---|---|
| 6.3% | — | — | — | — | — |
| 6.8% | — | — | — | — | — |
| 7.3% | — | — | — | — | — |
| 7.8% | — | — | — | — | — |
| 8.3% | — | — | — | — | — |
Now (TTM)
- Market cap
- ₩718B
- Enterprise value
- ₩698B
- P/E
- —
- P/B
- 6.9×
- P/S
- 31.5×
- EV/EBITDA
- —
- Dividend yield
- 0.0%
Over time (at each year end)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Price | ₩17,850 | ₩5,680 | ₩2,915 | ₩3,765 | ₩4,725 |
| Market cap | ₩668B | ₩213B | ₩109B | ₩141B | ₩177B |
| P/E | — | — | — | — | — |
| P/B | 9.7× | 8.5× | 4.2× | 5.1× | 5.4× |
| P/S | 34.6× | 13.4× | 5.0× | 8.3× | 7.7× |
| EV/EBITDA | — | — | — | — | — |
| Dividend yield | 0.0% | — | — | — | — |
Versus similar companies
| Company | P/E | P/B | P/S | EV/EBITDA | Dividend yield |
|---|---|---|---|---|---|
| JS Link | — | 6.9× | 31.5× | — | 0.0% |
| Samsung Biologics | 31.9× | 7.6× | 13.9× | — | 0.0% |
| Celltrion | 27.9× | 2.5× | 9.0× | — | 0.0% |
| Alteogen | 79.4× | 28.6× | 60.3× | — | 0.1% |
| SK biopharmaceuticals | 15.2× | 6.0× | 7.1× | — | 0.0% |
| Yuhan | 23.2× | 2.3× | 2.4× | 30.2× | 0.8% |
| HLB | — | 15.4× | 54.3× | — | 0.0% |
| Similar companies (median) | 27.9× | 6.8× | 11.4× | 30.2× | 0.0% |
Calculated from end-of-day prices and filed financial statements. Not a recommendation. This is not financial advice.
Also known as: JS Link / 제이에스링크 / 127120 / KRX:127120
Source: KRX statistical information